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Abstract
Wire-based fractional flow reserve (FFR) is a diagnostic tool used to evaluate the ischemic burden of 
coronary lesions. Large-scale studies have shown that FFR-guided revascularization is associated with 
better clinical outcomes. However, wide adoption of this technology is limited due to the considerable 
cost, additional time needed for set-up and performance of the measurement as well as the invasiveness 
of the procedure which requires pressure wire placement across the lesion into the distal segment of the 
coronary artery. To overcome these limitations new, promising, and less-/non-invasive methods were 
developed. These methods are based on computational fluid dynamics analysis and three-dimensional 
lumen reconstruction. The aim of this paper is to review scientific evidence supporting the clinical safety 
and efficacy of these techniques, such as instantaneous wave-free ratio, quantitative flow ratio and FFR 
calculated from computed tomographic angiography. (Cardiol J XXXX; XX, X: xx–xx)
Key words: coronary angiography, quantitative flow ratio, computational fluid  
dynamics, fractional flow reserve
Introduction
Coronary artery disease (CAD) is one of the 
main causes of morbidity and mortality in devel-
oped countries [1, 2]. Coronary angiography re-
mains the gold standard for the diagnosis of CAD, 
however, its ability to differentiate ischemic from 
non-ischemic lesions is limited. In this respect, 
fractional flow reserve (FFR), which takes into 
consideration the functional severity of coronary 
stenosis, outperforms the traditional diagnostic 
approach, based solely on morphometric assess-
ment [3, 4]. Unfortunately, the adoption of FFR in 
everyday clinical practice is slow and is utilized in 
only a minority of centers [5, 6]. Härle et al. [7] 
found that FFR was used in 3.2% of all diagnostic 
procedures performed in Germany. In Poland pen-
etration rate of FFR was even lower and did not 
exceed 2% in 2014 [8]. The main limiting factors 
include: 1) considerable time need for set-up and 
conduction of the examination; 2) high cost of 
diagnostic probe and adenosine infusion; 3) in-
vasiveness, as it requires insertion of a pressure 
wire across the lesion into the distal part of the 
vessel, which is associated with increased risk of 
serious complications, e.g. ventricular arrhyth-
mias and coronary vessel dissection (occurring 
in 0.5% of procedures), and 4) patient-related 
contraindications (hypotension, asthma, second-
degree atrioventricular blocks) [9–11]. To over-
come these limitations, less invasive techniques 
based on computational fluid dynamics (CFD) and 
three-dimensional (3D) lumen reconstruction 
have been proposed [12–16].
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Pressure wire methods
Instantaneous wave-free ratio
Instantaneous wave-free ratio (iFR) is one 
alternative method that does not require adeno-
sine infusion (Fig. 1). Although vessel wiring is 
still necessary, iFR measurements are quicker 
to perform and are cheaper than FFR. The sci-
entific basis came from findings by Sen et al. [17] 
who demonstrated that functional assessment of 
coronary lesions comparable to FFR is possible 
without drug induced hyperemia, during the so-
called “wave-free period”. This period is seen in 
diastole and characterized by minimal and stable 
coronary resistance (similar to “hyperemic-like” 
conditions), which makes the trans-stenotic pres-
sure gradient corresponding directly to flow and 
lesion severity [17].
The first published clinical study evaluating 
the correlation between iFR and FFR (ADenosine 
Vasodilator Independent Stenosis Evaluation [AD-
VISE]) demonstrated a close correlation between 
values obtained with these two methods (r = 0.9; 
p < 0.001) [17]. The possibility of iFR real-time 
measurement was proven by ADVISE in-practice 
study. The authors assessed 392 angiographically 
intermediate lesions and demonstrated that the 
best cutoff value of iFR corresponding to FFR ≤ 
0.80 was an iFR ≤ 0.90 and resulted in classifica-
tion agreement in 80% of cases, specificity of 
79%, sensitivity of 81%, positive predictive value 
(PPV) of 71% and negative predictive value (NPV) 
of 87% [18]. What is more, it was shown that iFR 
correlates more closely than FFR with coronary 
flow velocity reserve, which suggests that iFR 
may be a more physiological parameter of disease 
severity [19]. 
In 2017, two pivotal trials evaluating iFR in 
clinical practice were published. The Functional 
Lesion Assessment of Intermediate Stenosis to 
Guide Revascularization (DEFINE-FLAIR) trial 
consisting of almost 2500 patients with stable CAD, 
proved that iFR-guided is noninferior to FFR-
guided coronary revascularization with respect to 
composite risk of death from any cause, nonfatal 
myocardial infarction (MI) or unplanned revascu-
larization during 1-year follow-up. Additionally, 
study results showed that in iFR group median 
procedural time was significantly shorter (40.5 
vs. 45 min; p = 0.001; iFR vs. FFR, respectively) 
and fewer patients had adverse procedural symp-
toms (3.1% vs. 30.8%; p < 0.001; iFR vs. FFR, 
respectively) [20]. The Instantaneous Wave-free 
Ratio versus Fractional Flow Reserve in Patients 
with Stable Angina Pectoris or Acute Coronary 
Syndrome (iFR-SWEDE-HEART) trial consisting 
of over 2000 patients with stable CAD or acute 
coronary syndrome (17.5% patients) showed 
similar results. The primary composite end-point 
(defined as composite of death from any cause, 
nonfatal MI or unplanned revascularization) oc-
curred in 6.7% of the patients in the iFR group 
and in 6.1% of the patients in the FFR group in 
1-year follow-up (p = 0.007 for noninferiority). 
Figure 1. Vessel evaluation with instantaneous wave-free ratio (iFR) method indicates significant lesion in left ante-
rior descending (LAD) artery (iFR = 0.68); A. Coronary angiogram with wire position in distal LAD; B. The iFR with 
pullback recording using ScoutTM software.
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Authors, just as in the previously described study, 
reported that chest discomfort occurred less often 
during the iFR-guided procedure (3.0% vs. 68.3%; 
p < 0.001) [21]. Results of these two trials were 
reflected in European and in American guidelines, 
in which iFR was regarded as equivalent to FFR in 
hemodynamic assessment of intermediate-grade 
stenosis [22, 23]. 
Alternative pressure wire methods
Over the years other adenosine-free methods 
based on assessment of diastolic resting indices 
have been proposed. Recently published data 
proved a high correlation between iFR and resting 
distal coronary to aortic pressure (Pd/Pa). Both were 
associated with lesion anatomic and hemodynamic 
severity, showing excellent agreement between 
them [24, 25]. It seems that the adoption of Pd/Pa 
could be easier, in comparison to iFR, it was ana-
lyzable in a significantly higher number of cases 
[25]. Other diastolic resting indexes included 
resting Pd/Pa during the complete duration of 
diastole, in 25% to 75% of diastole, at midpoint 
of diastole (Fig. 2). All the above-mentioned 
parameters were proven to be identical to iFR, 
not only numerically, but also with respect to 
their agreement to FFR [26]. Though, they are 
all very promising, further studies are needed 
to evaluate their clinical value. 
Computational-based methods
Quantitative flow ratio
In 2013 Morris et al. [13] published results 
from the VIRTUal FFR From Coronary Angiog-
raphy (VIRTU-1) study, designed to demonstrate 
the feasibility of FFR computations based solely 
on two-dimensional (2D) coronary angiography 
images (virtual FFR [vFFR]). The study popula-
tion consisted of 19 patients. Compared to FFR, 
vFFR had an accuracy of 97%, sensitivity of 86%, 
specificity of 100%, PPV of 100%, and NPV of 97%. 
Although, there was a strong correlation between 
vFFR and wire-based FFR (r = 0.84), the image 
analysis was labor- and time-consuming, requiring 
24 h to process the above-mentioned data. Of note, 
authors used a “one-size fits all” approach, which 
assumed constant coronary vessel resistance. Such 
an assumption carries the risk of stenosis misclas-
sification due to possible changes in downstream 
microcirculatory resistance [13]. 
Papafakis et al. [27] proposed virtual functional 
assessment index (vFAI) — a quick method of 
functional assessment of intermediate coronary 
lesions, which took only 15 min to analyze one 
vessel. This approach computes distal to proximal 
pressure ratio over the lesion based on 3D quanti-
tative coronary angiography (QCA) reconstruction 
and steady-flow CFD. The method was compared 
to FFR in 120 patients showing accuracy of 88%, 
sensitivity of 90% and specificity of 86% for the 
optimal vFAI cut-off point (≤ 0.82). Additionally, 
the vFAI was superior to 3D QCA in predicting 
hemodynamic significance of coronary stenosis 
and demonstrated close correlation and good 
agreement with wire-based FFR values. The 
main limitation of vFAI, which is based solely on 
lesion geometry, is the fact that it does not take 
into account microvascular resistance and size of 
myocardial territory subtended by the vessel [27]. 
To overcome these limitations, the computed 
FFR (FFRQCA) based on mean volumetric flow rate 
at hyperemia derived from 3D vessel invasive coro-
nary angiography (ICA) reconstruction, Throm-
bolysis in Myocardial Infarction (TIMI) frame 
count and CFD utilization was proposed (Fig. 3). 
The analysis of 77 vessels provided an 88% overall 
accuracy of FFRQCA for diagnosis of ischemia (de-
fined as FFR ≤ 0.8). There was a strong correla-
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Figure 2. Resting Pd/Pa ratios over different periods of 
diastole. Based on [26]. Pd — resting distal coronary 
pressure; Pa — aortic pressure; Pd/Pa — resting distal 
coronary to aortic pressure; iFR — instantaneous wave-
free ratio; dPR — Pd/Pa during the complete duration 
of diastole; dPR25–75 — Pd/Pa in 25% to 75% of diastole; 
dPRmid — Pd/Pa in midpoint of diastole.
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tion between FFRQCA and FFR values (r = 0.81, 
p < 0.001) with a mean difference of ± 0.06 
(p = 0.054) [12].
One of the main advantages of this method 
is short computation time, which did not exceed 
10 min in total processing. Additionally, this method 
provides an evaluation of the entire coronary tree, 
whereas in wire-based FFR, only those lesions 
in which a pressure wire is inserted can be as-
sessed [28].
Further confirmation of diagnostic accuracy of 
fast computational approaches came from prospec-
tive, observational, multicenter Functional Assess-
ment by Various Flow Reconstruction (FAVOR) 
pilot study, in which 3 different quantitative flow 
ratio (QFR) computations were compared with 
standard wire-based FFR measurements. These 
included: 1) fixed-flow QFR (fQFR) that assumed 
a universal hyperemic flow velocity of 0.35 m/s); 
2) contrast-flow QFR (cQFR) based on individual 
virtual flow derived from the frame count dur-
ing contrast injection; 3) adenosine-flow (aQFR) 
based on individual virtual flow derived from the 
frame count during maximal adenosine-induced 
hyperemia. Authors confirmed good agreement 
between wire-based FFR and each QFR computa-
tion. The diagnostic accuracy was comparable for 
cQFR (86%) and aQFR (87%) and was significantly 
higher compared to fQFR (80%) indicating that the 
use of adenosine is not needed in this method [29]. 
Recently QFR received Conformité Européenne 
(CE) certificate, allows for wider adoption to eve-
ryday clinical practice. 
In 2017, results from The FAVOR II China 
(Functional Diagnostic Accuracy of Quantitative 
Flow Ratio in Online Assessment of Coronary 
Stenosis) study were also published. They pro-
spectively enrolled 308 consecutive patients at 
5 centers in China. The primary endpoint was to 
assess if QFR would improve diagnostic accuracy 
of coronary angiography. Authors met the pre-
specified performance goal for level of diagnostic 
accuracy of QFR in identifying hemodynamically 
significant stenosis. Additionally, they confirmed 
QFR to have 94.6% sensitivity, 91.7% specificity, 
85.5% PPV, and 97.1% NPV and diagnostic accuracy 
of 92.4% in patient-level analysis, and 92.7% in 
vessel-level analysis [30].
Figure 3. Computation of quantitative flow ratio (QFR) from coronary angiography; A. Angiographic projections of 
the left anterior descending (LAD) artery at > 25° apart; B. Fractional flow reserve (FFR) measured during intravenous 
adenosine infusion was 0.73; C. Computed QFR value indicates ischemia (QFR = 0.73). Arrow indicates original loca-
tion of pressure transducer.
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A recently published study  demonstrated ret-
rospectively analyzed results of 306 intermediate 
lesions, which had been previously evaluated using 
FFR. In contradiction to previous studies, which 
utilized core-lab assessment, in this particular 
study used an on-site QFR calculation in all cases. 
It showed that the Pearson correlation was strong 
for QFR (r = 0.85). Additionally, optimal QFR deci-
sion value of 0.79 was identified, this corresponded 
to FFR = 0.80 (AUC = 0.94). After introduction of 
the cut-off value of ≤ 0.74 and > 0.83, an excellent 
diagnostic performance of QFR was achieved, with 
sensitivity and specificity > 95%. Additionally, it 
was confirmed that the time for QFR analysis was 
relatively short and substantially decreased with 
the number of analyzed cases. The first 50 QFR 
analysis took an  average of 5 min 59 s, whereas in 
the final 50 cases the mean time was 2 min 7 s [31].
Westra et al. [32] prospectively evaluated QFR 
in 240 lesions and correctly classified 83% of the 
lesions when an FFR cut off value of 0.8 was used. 
They also achieved a sensitivity of 77%, specificity 
of 86%, PPV of 87%, and NPV of 75%. 
In 2018 the results from The FAVOR II Eu-
rope-Japan Study were published. In this interna-
tional, multicenter trial 329 patients were enrolled. 
QFR values were calculated online in catherization 
laboratories during the procedure. Sensitivity and 
specificity were > 86% for QFR, which was signifi-
cantly higher than for 2D QCA (sensitivity 44.2%; 
p < 0.001 and specificity 76.5%; p = 0.002) [33].
The most recently published study demon-
strated that QFR may also be utilized in acute 
coronary syndrome settings, particularly in  guid-
ing non-culprit lesion revascularization in patients 
presenting with ST-segment elevation MI [34]. 
Additionally, the QFR good inter-core laboratory 
reproducibility had already been proven [35].
Although QFR is a very promising method, 
there are some technical limitations that should 
be taken into account. At present, the degree of 
flow-limiting stenosis of the ostial left main and 
ostial right coronary artery lesions cannot be reli-
ably measured. Supraventricular tachyarrhythmia 
leading to an altered filling pattern of coronary 
arteries remains an exclusion criterion for FFRQCA 
calculation. Additionally, patients with coronary ar-
tery bypass grafting supplying evaluated vessels or 
with collateral circulation have not been adequately 
studied [12]. Last, the timing of contrast injection 
may also affect the FFRQCA values. 
Additionally, data on clinical outcomes i.e. pa-
tient quality of life and cost-effectiveness remains 
lacking. This gap may will hopefully be addressed 
by the upcoming FAVOR III trial, which is de-
signed as a prospective, randomized, multicenter 
clinical outcome study. With a planned enrollment 
of approximately 2000 patients, it is powered to 
establish the role of this method in the diagnostic 
process of CAD patients. 
Computed tomographic angiography
Computed tomographic angiography (CTA) of 
the coronary vessels was the first non-invasive 
diagnostic imaging method providing data for 
CFD analysis to derive FFR-equivalent mea-
surements (Fig. 4). Koo et al. [14] analyzed 103 
patients, who underwent coronary CTA, QCA 
and FFR measurement. They performed the 
computation of FFR from coronary CTA (FFRCT) 
using a powerful supercomputer to calculate the 
above-mentioned values. The proposed method 
utilized semi-automated segmentation of coronary 
arteries and approximation of the left ventricular 
mass. Despite the high computing power, a single 
analysis took approximately 5 h. The FFRCT had 
an accuracy of 84.3%, sensitivity of 87.9%, speci-
ficity of 82.2%, PPV of 73.9%, and NPV of 92.2% 
for the diagnosis of ischemia-inducing lesions on 
a per-vessel basis. Additionally, there was a good 
Figure 4. Coronary computed tomography angiog-
raphy-derived fractional flow reserve indicates no is-
chemia in right coronary artery with computed value 
of 0.94, and hemodynamically significant lesion in left 
anterior descending artery with measured value of 0.76 
[Image by courtesy of Drs. Christian Tesche and Maksy-
milian P. Opolski].
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correlation between FFRCT and FFR values, with 
a slight underestimation by FFRCT (0.022 ± 0.116; 
p = 0.016). Authors concluded that the addition 
of FFRCT to standard coronary CTA measure-
ments might enhance diagnostic accuracy and this 
method’s utility [14].
Min et al. [15] studied 252 stable patients 
who underwent coronary CTA, QCA and FFR 
measurements. Patients with a history of coronary 
artery bypass grafting or with suspected in-stent 
restenosis on the basis of CT were excluded. The 
FFRCT calculation was also based on coronary 
CTA. One analysis took up to 6 hours. Authors 
reported FFRCT’s accuracy of 73%, sensitivity of 
90%, specificity of 54%, PPV of 67%, and NPV of 
84% for diagnosis of ischemia-inducing lesions 
on a per-patient basis. The study did not achieve 
its pre-specified level of per-patient diagnostic 
accuracy, however, it showed that adding FFRCT 
analysis to plain CTA assessment improved diag-
nostic accuracy. Authors emphasized that FFRCT 
had high negative predictive value and high sen-
sitivity, indicating that coronary angiogram is not 
needed when FFRCT’s results are normal, despite 
significant stenosis in CTA [15]. 
A refined version of FFRCT calculation was 
evaluated by Nørgaard et al. [16] who studied 254 
patients with coronary CTA, QCA and FFR meas-
urements. The new approach was significantly 
quicker with a mean time to results of less than 
4 h (depending on CT scan quality and CAD bur-
den). On a per-vessel basis, authors found diagnos-
tic accuracy of 86%, sensitivity of 84%, specificity 
of 86%, PPV of 61%, and NPV of 95% for FFRCT 
under 0.8, which correlated well with FFR values 
under 0.8. They concluded that FFRCT has high 
diagnostic performance compared with standard 
FFR measurements [16].
The multicenter Prospective Longitudinal 
Trial of FFRCT: Outcome and Resource Impacts 
(PLATFORM) trial evaluated FFRCT guided re-
vascularization looking at clinical outcomes, cost/
resource utilization and quality of life. Overall 
584 patients with new onset of chest pain were 
included. Patients were randomized to standard 
evaluation (usual care arm) and CTA/FFRCT testing. 
In the usual care arm, significantly more patients 
who underwent coronary angiography had no ob-
structive CAD when compared to CTA/FFRCT care 
arm (73.3% vs. 12.4%; p < 0.0001). This observa-
tion was further confirmed in a propensity score 
matching analysis of 148 pairs (72% vs. 12%; p < 
0.0001). Most importantly there were no major 
adverse cardiac events over the 90-day follow-up 
8 www.cardiologyjournal.org
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defined as total coronary vessel lumen volume 
relative to left ventricular mass, has a statisti-
cally significant influence on FFRCT’s accuracy 
and specificity.
Conclusions
Functional assessment of coronary arteries 
remains a gold standard in the diagnosis of patients 
with intermediate coronary artery stenosis. In 
current clinical practice, the adoption of traditional 
wire-based FFR technology is slow and limited 
by clinical safety and economic constraints. QFR 
and FFRCT are the new, less-/non-invasive compu-
tational methods that have recently emerged as 
promising diagnostic tools. The currently avail-
able body of evidence, though limited, provides 
solid grounds in recognizing these technologies as 
strong candidates to reduce the number of wire-
based FFR examinations (Table 1). Advantages and 
disadvantages of above-mentioned diagnostic tools 
are summed up in Table 2.
It is thought herein, that all these methods 
will find their place in the management of patients 
with CAD. It seems that QFR and FFRCT should 
be perceived as more complementary, rather than 
competitive modalities. While FFRCT may lead to 
better identification of patients who would not 
benefit from ICA investigation, QFR may be used 
on-line to assess the hemodynamic significance of 
a lesion during ICA and eliminate risks associated 
with wiring of a coronary artery. It is essential to 
utilize cut-off values in which QFR has excellent 
agreement with FFR measurements (“grey-zone” 
concept). If results of the upcoming clinical valida-
tion will be positive, one may foresee a change in 
the current diagnostic algorithm by incorporating 
period for any patient in whom ICA was canceled 
based on negative results of the CTA/FFRCT [36]. 
Further confirmation of FFRCT diagnostic 
value comes from a recently published cohort of 
almost 700 patients, who underwent FFRCT evalu-
ation. The composite endpoint included all-cause 
death, MI, hospitalization for unstable angina, and 
unplanned revascularization. Patients were divided 
into four groups: 1) patients with coronary steno-
sis < 30% in CTA, who received optimal medical 
treatment (OMT); 2) patients with FFRCT > 0.8, 
who also received OMT; 3) patients with FFRCT ≤ 
0.80, who did not undergo any further testing and 
received OMT; 4) patients with FFRCT ≤ 0.80, who 
on the top of OMT were referred to ICA. Risk of 
MI was higher in group 3 than in group 4 (8% vs. 
1.3%; p < 0.001), indicating that FFRCT is an ef-
fective diagnostic tool to differentiate patients with 
intermediate coronary lesions who may benefit 
from invasive treatment [37].  
In conclusion, the CTA/FFRCT analysis is a 
safe diagnostic method characterized however, 
by moderate diagnostic value. In patients already 
scheduled for CTA, adding FFRCT does not re-
quire additional imaging, radiation or medication 
[14–16]. Limitations of this method include long 
post-processing time, precluding online analysis 
and high cost. Additionally, the CTA dataset must 
be sent to a core laboratory to calculate FFR val-
ues. This is expensive and time-consuming. What 
is more, FFRCT is feasible only in CTA eligible 
patients, precluding a significant share of the 
CAD population, such as patients with massive 
calcifications, atrial fibrillation, previous stent 
implantation and others [38]. Moreover, vessel 
size may affect FFRCT values as well. Recently 
Gaur et al. [39] proved that volume-to-mass ratio, 
Table 2. Comparison of alternative methods of functional assessment of intermediate stenosis. 
Comparator FFR iFR QFR FFRCT
Invasiveness:
Contrast + + + +
Invasive coronary angiography + + + –
Pressure wire + + – –
Adenosine + – – –
Data acquisition and processing time 8–10 min* 5–7 min* 3–5 min* 4–6 h*
Online/offline processing Online Online Online Offline
Costs +++ ++ + ++++
*Excluding standard invasive coronary angiography time and standard computed tomography angiography time; FFR — fractional flow reserve; 
FFRCT — FFR calculated from computed tomography; iFR — instantaneous wave-free ratio; QFR — quantitative flow ratio
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alternative methods for functional assessment of 
intermediate coronary lesions (Fig. 5). 
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